Roivant Sciences (ROIV) Current Taxes (2022 - 2026)
Roivant Sciences (ROIV) reported Current Taxes of $45.7 million for Q1 2026, up 10882.93% on a YoY basis from N/an in Q1 2025, and up 10882.93% quarter-over-quarter from $416000.0 in Q1 2025.
Roivant Sciences (ROIV) Current Taxes (2022 - 2026) Analysis & Trends
Roivant Sciences has reported Current Taxes for 5 years, with the latest figure at $45.7 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes rose 10882.93% year-over-year to $45.7 million; the trailing twelve-month figure through Mar 2026 stood at $45.7 million (up 10882.93% YoY), and the FY2026 full-year result was $45.7 million, up 10882.93% from the prior year.
- Current Taxes for Q1 2026 stood at $45.7 million, up from $416000.0 in the prior quarter.
- The five-year high for Current Taxes was $45.7 million in Q1 2026, with the low at $416000.0 in Q1 2025.
- Historically, Current Taxes has averaged $10.0 million across 5 years, with a median of $3.4 million in 2023.
- Annual changes were most pronounced in 2024 — Current Taxes plunged 97.72% — and 2026, when it jumped 10882.93%.
- Roivant Sciences' Current Taxes stood at $5.6 million in 2022, then jumped by 347.45% to $25.2 million in 2023, then sank by 97.72% to $576000.0 in 2024, then decreased by 27.78% to $416000.0 in 2025, then jumped by 10882.93% to $45.7 million in 2026.
- The last three Current Taxes figures came in at $45.7 million (Q1 2026), $416000.0 (Q1 2025), and $576000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | 45.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.69 Mn |
| Mar 31, 2025 | 416,000.00 |
| Dec 31, 2024 | 576,000.00 |
| Sep 30, 2024 | 5.41 Mn |
| Jun 30, 2024 | 23.44 Mn |
| Mar 31, 2024 | 9.77 Mn |
| Dec 31, 2023 | 25.22 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 542,000.00 |
| Dec 31, 2022 | 5.64 Mn |
| Mar 31, 2022 | 708,000.00 |